InfuSystem to Present at 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025 (Form 8-K)

InfuSystem to Present at 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025

Rochester Hills, Michigan, September 25, 2025 - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today Carrie Lachance, CEO and Barry Steele, Chief Financial Officer, will participate at the 4th Annual ROTH Healthcare Opportunities Conference on Thursday, October 9, 2025. The conference will be held at the Metropolitan Club in New York City.

Management is scheduled to host virtual one-on-one meetings throughout the day. Investors interested in arranging one-on-one meetings should contact your conference representative. Conversely, you may also call or email Lytham Partners at 602-889-9700, or [email protected].

.

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada.